Article metrics

Download PDFPDF

38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results
Free

 

Online download statistics by month:

Online download statistics by month: September 2019 to October 2024

AbstractFullPdf
Sep 20192409
Oct 20192705
Nov 20191603
Dec 20192004
Jan 2020601
Feb 2020602
Mar 2020802
Apr 20203003
May 20201601
Jun 20203809
Jul 20202103
Aug 20201003
Sep 20203203
Oct 20204606
Nov 20204403
Dec 20202202
Jan 20214208
Feb 20211102
Mar 20212602
Apr 20211805
May 2021303
Jun 2021007
Jul 2021002
Aug 2021002
Sep 2021003
Oct 20216019
Nov 202126014
Dec 20212202
Jan 20221401
Feb 20222603
Mar 20221800
Apr 2022602
May 202224011
Jun 20221604
Jul 20221201
Aug 20221706
Sep 20221306
Oct 20222802
Nov 2022803
Dec 20222401
Jan 2023401
Feb 20231803
Mar 20231602
Apr 20231002
May 20231101
Jun 2023400
Jul 20231403
Aug 2023604
Sep 20231001
Oct 2023500
Nov 20231802
Dec 20231300
Jan 2024801
Feb 20241402
Mar 202421019
Apr 2024604
May 20241002
Jun 20241300
Jul 2024600
Aug 20241205
Sep 2024802
Oct 2024400
Total9570222